Norwegian and Australian researchers conducted a randomised trial with 81 women with endometriosis to investigate the impact of supervised exercise and pelvic floor muscle training on pelvic and genital pain. Lead author Rakel Gabrielsen agreed to answer some questions about the trial.

Canadian researcher Teresa Liu-Ambrose is a keynote speaker at APASC25. Here she answers some questions from physiotherapy researcher Dr Jo-Aine Hang about her upcoming presentation.

APASC25 keynote speaker Associate Professor Chris Burtin talks to lecturer and physiotherapist Dr Georgina Whish-Wilson about exercise approaches for patients with chronic respiratory conditions.

Physiotherapy lecturer and researcher Dr Lara Edbrooke talks to Dr Vin Cavalheri about what to expect from his keynote presentation for the Cancer, Palliative Care and Lymphoedema stream at APASC25.

Lifestyle medicine physician Dr Jenny Brockis will deliver a keynote address for the Mental Health stream at APASC25 and present a half-day pre-conference workshop. Ruth Lira, chair of the Western Australia branch of the Mental Health national group, asks her how physiotherapists can integrate lifestyle medicine into their practice.

Researchers from the University of Exeter and collaborators across the UK and Australia analysed data from the BOOST trial, a major physiotherapy study that tested a 12-week program for older adults with painful walking due to lumbar spinal stenosis. Lead author Dr Lianne Wood and author Dr Esther Williamson agreed to answer some questions about the research.

PD PROFILE Professor Anna Campbell, who designed ‘Cancer and exercise rehabilitation’, answers some questions about the course.

Associate Professor Ebonie Rio, who presents ‘Sports Physiotherapy Level 3’ alongside Professors Craig Purdam and Jill Cook, answers some questions about the latest version of the course.

JOURNAL OF PHYSIOTHERAPY Read about the latest research covered in the July issue of the Journal.

LOW BACK PAIN While dozens of low back pain treatments have been tested in patients, two recent systematic reviews using meta-analysis to compare data from multiple trials have shown that very few treatments have enough high-quality evidence about their efficacy.